Advanced polymeric matrix for valvular complications

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 5, 2012, Pages 1151-1159

  Acharya, Gayathri ^a   Hopkins, Richard A ^b   Lee, Chi H ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

nitric oxide; NO releasing; PLGA nanoparticles; PLLA matrix; valvular complication

Indexed keywords

ALKALINE PHOSPHATASE ACTIVITY; ANTICALCIFICATION; AORTIC VALVES; CALCIUM CONTENT; CELL VIABILITY; CONTROLLED DELIVERY; CONTROLLED RELEASE; CYTOTOXIC ACTIVITIES; DRUG RELEASE; GUANOSINES; HEART VALVES; ICAM-1 EXPRESSION; INHIBITORY ACTIVITY; INTERCELLULAR ADHESION MOLECULES; MATRIX SYSTEMS; MONOPHOSPHATES; NO DONOR; NO RELEASE; NO-RELEASING; PHARMACOLOGICAL RESPONSE; PLGA NANOPARTICLES; PLLA; POLY L LACTIC ACID; POLY(LACTIC-CO-GLYCOLIC ACID); POLYMERIC MATRICES; SALT-LEACHING METHOD; SIGNALING PATHWAYS; TISSUE INFLAMMATION; VALVULAR COMPLICATION;

BIOMINERALIZATION; BONE; CELL ADHESION; LACTIC ACID; LEACHING; NANOPARTICLES; NITRIC OXIDE; PATHOLOGY; PHOSPHATASES; TISSUE;

CYTOTOXICITY;

ALKALINE PHOSPHATASE; CALCIUM; CYCLIC GMP; INTERCELLULAR ADHESION MOLECULE 1; NANOPARTICLE; NITRIC OXIDE DONOR; POLYGLACTIN; POLYLACTIC ACID; POLYMER; SODIUM CHLORIDE;

ANIMAL CELL; ARTICLE; CALCIFICATION; CELL CULTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RELEASE; ENZYME ACTIVITY; ENZYME ANALYSIS; EXTRACELLULAR MATRIX; IN VITRO STUDY; LEACHING; LEYDIG CELL; MEASUREMENT; MORPHOLOGY; NONHUMAN; OSTEOBLAST; PROTEIN EXPRESSION; ROOM TEMPERATURE; SIGNAL TRANSDUCTION; VALVULAR HEART DISEASE;

ALKALINE PHOSPHATASE; ANIMALS; AORTIC VALVE; CALCIFICATION, PHYSIOLOGIC; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CYCLIC GMP; DRUG DELIVERY SYSTEMS; HEART VALVE PROSTHESIS; INTERCELLULAR ADHESION MOLECULE-1; LACTIC ACID; NANOPARTICLES; NITROSO COMPOUNDS; POLYGLYCOLIC ACID; POROSITY; SUS SCROFA; TISSUE SCAFFOLDS;

EID: 84862799617     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34055     Document Type: Article

References (41)

1. Schoen FJ,. Pathologic considerations in replacement heart valves and other cardiovascular prosthetic devices. Monogr Pathol 1995; 37: 194-222.
2. Lee CH, Vyavahare N, Zand R, Kruth H, Schoen FJ, Bianco R, Levy RJ,. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: Biochemical and biophysical mechanisms. J Biomed Mater Res 1998; 42: 30-37. (Pubitemid 28412994)
3. Weska RF, Aimoli CG, Nogueira GM, Leirner AA, Maizato MJ, Higa OZ, Polakievicz B, Pitombo RN, Beppu MM,. Natural and prosthetic heart valve calcification: Morphology and chemical composition characterization. Artif Organs 2010; 34: 311-318.
4. Valente M, Bortolotti U, Thiene G,. Ultrastructural substrates of dystrophic calcification in porcine bioprosthetic valve failure. Am J Pathol 1985; 119: 12-21. (Pubitemid 15088720)
5. Simionescu A, Schulte JB, Fercana G, Simionescu DT,. Inflammation in cardiovascular tissue engineering: The challenge to a promise: A minireview. Int J Inflam 2011; 2011: 958247.
6. Golomb G, Dixon M, Smith MS, Schoen FJ, Levy RJ,. Inhibition of bioprosthetic heart valve calcification by sustained local delivery of Ca and Na diphosphonate via controlled release matrices. ASAIO Trans 1986; 32: 587-590.
7. Golomb G, Dixon M, Smith MS, Schoen FJ, Levy RJ,. Controlled-release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: Release rate modulation with silicone matrices via drug solubility and membrane coating. J Pharm Sci 1987; 76: 271-276. (Pubitemid 17118153)
8. Kanno Y, Into T, Lowenstein CJ, Matsushita K,. Nitric oxide regulates vascular calcification by interfering with TGF- signalling. Cardiovasc Res 2008; 77: 221-230. (Pubitemid 351195162)
9. Pradilla G, Thai QA, Legnani FG, Hsu W, Kretzer RM, Wang PP, Tamargo RJ,. Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery 2004; 55: 1393- 1399; discussion 1399-1400. (Pubitemid 39612889)
10. Yoo JW, Choe ES, Ahn SM, Lee CH,. Pharmacological activity and protein phosphorylation caused by nitric oxide-releasing microparticles. Biomaterials 2010; 31: 552-558.
11. Yoo JW, Lee JS, Lee CH,. Characterization of nitric oxide-releasing microparticles for the mucosal delivery. J Biomed Mater Res A 2009; 92: 1233-1243.
12. Barbanti SH, Santos AR, Jr., Zavaglia CA, Duek EA,. Porous and dense poly(L-lactic acid) and poly(D,L-lactic acid-co-glycolic acid) scaffolds: In vitro degradation in culture medium and osteoblasts culture. J Mater Sci Mater Med 2004; 15: 1315-1321. (Pubitemid 40385330)
13. Carfi-Pavia F, Turturici G, Geraci F, Brucato V, La Carrubba V, Luparello C, Sconzo G,. Porous poly (L-lactic acid) scaffolds are optimal substrates for internal colonization by A6 mesoangioblasts and immunocytochemical analyses. J Biosci 2009; 34: 873-879.
14. Lo H, Kadiyala S, Guggino SE, Leong KW,. Poly(L-lactic acid) foams with cell seeding and controlled-release capacity. J Biomed Mater Res 1996; 30: 475-484. (Pubitemid 26107080)
15. Liu AC, Joag VR, Gotlieb AI,. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007; 171: 1407-1418. (Pubitemid 350158303)
16. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH,. The cardiac valve interstitial cell. Int J Biochem Cell Biol 2003; 35: 113-118. (Pubitemid 35441268)
17. Babu AN, Meng X, Zou N, Yang X, Wang M, Song Y, Cleveland JC, Weyant M, Banerjee A, Fullerton DA,. Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis. Ann Thorac Surg 2008; 86: 71-76.
18. Cohen-Sela E, Chorny M, Koroukhov N, Danenberg HD, Golomb G,. A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles. J Control Release 2009; 133: 90-95.
19. Doijad RC, Manvi FV, Godhwani DM, Joseph R, Deshmukh NV,. Formulation and targeting efficiency of Cisplatin engineered solid lipid nanoparticles. Indian J Pharm Sci 2008; 70: 203-207. (Pubitemid 351920197)
20. Hu FQ, Yuan H, Zhang HH, Fang M,. Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 2002; 239: 121-128. (Pubitemid 34615801)
21. Chen G, Ushida T, Tateishi T,. A biodegradable hybrid sponge nested with collagen microsponges. J Biomed Mater Res 2000; 51: 273-279. (Pubitemid 30387644)
22. Mikos AG, Lyman MD, Freed LE, Langer R,. Wetting of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 1994; 15: 55-58.
23. Zong X, Bien H, Chung CY, Yin L, Fang D, Hsiao BS, Chu B, Entcheva E,. Electrospun fine-textured scaffolds for heart tissue constructs. Biomaterials 2005; 26: 5330-5338. (Pubitemid 40462348)
24. Anthamatten M, Letts SA, Cook RC,. Controlling surface roughness in vapor-deposited poly(amic acid) films by solvent-vapor exposure. Langmuir 2004; 20: 6288-6296.
25. Tang ZG, Black RA, Curran JM, Hunt JA, Rhodes NP, Williams DF,. Surface properties and biocompatibility of solvent-cast poly[-caprolactone] films. Biomaterials 2004; 25: 4741-4748. (Pubitemid 38561161)
26. Taylor PM, Sachlos E, Dreger SA, Chester AH, Czernuszka JT, Yacoub MH,. Interaction of human valve interstitial cells with collagen matrices manufactured using rapid prototyping. Biomaterials 2006; 27: 2733-2737. (Pubitemid 43122077)
27. Dondas HA, Yilmaz N, Comelekoglu U, Tamer L, Sucu N, Aytacoglu BN, Ozeren M, Kose N, Dikmengil M,. Prevention of calcification with TPEN in pericardial bioprosthetic heart valve material. Anadolu Kardiyol Derg 2007; 7: 365-370. (Pubitemid 350303382)
28. Chung YI, Ahn KM, Jeon SH, Lee SY, Lee JH, Tae G,. Enhanced bone regeneration with BMP-2 loaded functional nanoparticle-hydrogel complex. J Control Release 2007; 121: 91-99. (Pubitemid 47126068)
29. Yoo JW, Acharya G, Lee CH,. In vivo evaluation of vaginal films for mucosal delivery of nitric oxide. Biomaterials 2009; 30: 3978-3985.
30. Buras JA, Stahl GL, Svoboda KK, Reenstra WR,. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: The role of NOS. Am J Physiol Cell Physiol 2000; 278: C292-C302. (Pubitemid 30131146)
31. Cushing MC, Liao JT, Anseth KS,. Activation of valvular interstitial cells is mediated by transforming growth factor-beta1 interactions with matrix molecules. Matrix Biol 2005; 24: 428-437. (Pubitemid 41781640)
32. Studzinski GP,. Cell Growth, Differentiation, and Senescence: A Practical Approach. Oxford; New York: Oxford University Press; 1999.
33. Yoshioka T, Kamada F, Kawazoe N, Tateishi T, Chen G,. Structural changes and biodegradation of PLLA, PCL, and PLGA sponges during in vitro incubation. Polym Eng Sci 2010; 50: 1895-1903.
34. Iwai S, Sawa Y, Ichikawa H, Taketani S, Uchimura E, Chen G, Hara M, Miyake J, Matsuda H,. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. J Thorac Cardiovasc Surg 2004; 128: 472-479. (Pubitemid 39194708)
35. Van Lieshout M, Peters G, Rutten M, Baaijens F,. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Eng 2006; 12: 481-487. (Pubitemid 43673453)
36. Jain RA,. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21: 2475-2490.
37. Lazzeri L, Cascone MG, Danti S, Serino LP, Moscato S, Bernardini N,. Gelatine/PLLA sponge-like scaffolds: Morphological and biological characterization. J Mater Sci Mater Med 2007; 18: 1399-1405. (Pubitemid 47007606)
38. Schoen FJ, Hobson CE,. Anatomic analysis of removed prosthetic heart valves: Causes of failure of 33 mechanical valves and 58 bioprostheses, 1980 to 1983. Hum Pathol 1985; 16: 549-559. (Pubitemid 15049628)
39. Warrier B, Mallipeddi R, Karla PK, Lee CH,. The functional role of C-reactive protein in aortic wall calcification. Cardiology 2005; 104: 57-64. (Pubitemid 41197013)
40. Biffl WL, Moore EE, Moore FA, Barnett C,. Nitric oxide reduces endothelial expression of intercellular adhesion molecule (ICAM)-1. J Surg Res 1996; 63: 328-332. (Pubitemid 26197215)
41. Kupatt C, Weber C, Wolf DA, Becker BF, Smith TW, Kelly RA,. Nitric oxide attenuates reoxygenation-induced ICAM-1 expression in coronary microvascular endothelium: Role of NFkappaB. J Mol Cell Cardiol 1997; 29: 2599-2609. (Pubitemid 27466483)